Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19.
Mayo Clin Proc Innov Qual Outcomes
; 6(6): 511-524, 2022 Dec.
Article
em En
| MEDLINE
| ID: mdl-36117954
AUC, area under curve; COVID-19, coronavirus disease 2019; CP, convalescent plasma; CPT, convalescent plasma therapy; IgG, immunoglobulin G; RCT, randomized controlled trial; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; SERPINA1, serine protease inhibitors A1 (or alpha 1 anti-trypsin); SOC, standard of care
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
Idioma:
En
Revista:
Mayo Clin Proc Innov Qual Outcomes
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Índia